0001479290-18-000123.txt : 20181214 0001479290-18-000123.hdr.sgml : 20181214 20181214212315 ACCESSION NUMBER: 0001479290-18-000123 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181214 FILED AS OF DATE: 20181214 DATE AS OF CHANGE: 20181214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Joshi Abhay CENTRAL INDEX KEY: 0001359089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 181236858 MAIL ADDRESS: STREET 1: C/O REVANCE THERAPEUTICS, INC. STREET 2: 7555 GATEWAY BOULEVARD CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 4 1 wf-form4_154484057233025.xml FORM 4 X0306 4 2018-12-14 0 0001479290 Revance Therapeutics, Inc. RVNC 0001359089 Joshi Abhay C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 Chief Operating Officer Common Stock 2018-12-14 4 F 0 4260 19.91 D 80003 D Represents the number of shares withheld by and surrendered to the issuer on December 14, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of a 2014 Restricted Stock Award ("RSA") for 8,594 shares. The RSA vests in four equal annual installments from December 14, 2016, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date. /s/ Gordon Ho, Attorney-in-Fact 2018-12-14